Paraneoplastic Thrombocytosis in Ovarian Cancer
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear. METHODS: We analyzed clinical data on 619 patients with epithelial ovarian cancer to test associations between platelet counts and disease outcome. Human samples and mouse models of epithelial ovarian cancer were used to explore the underlying mechanisms of paraneoplastic thrombocytosis. The effects of platelets on tumor growth and angiogenesis were ascertained. RESULTS: Thrombocytosis was significantly associated with advanced disease and shortened survival. Plasma levels of thrombopoietin and interleukin-6 were significantly elevated in patients who had thrombocytosis as compared with those who did not. In mouse models, increased hepatic thrombopoietin synthesis in response to tumor-derived interleukin-6 was an underlying mechanism of paraneoplastic thrombocytosis. Tumor-derived interleukin-6 and hepatic thrombopoietin were also linked to thrombocytosis in patients. Silencing thrombopoietin and interleukin-6 abrogated thrombocytosis in tumor-bearing mice. Anti-interleukin-6 antibody treatment significantly reduced platelet counts in tumor-bearing mice and in patients with epithelial ovarian cancer. In addition, neutralizing interleukin-6 significantly enhanced the therapeutic efficacy of paclitaxel in mouse models of epithelial ovarian cancer. The use of an antiplatelet antibody to halve platelet counts in tumor-bearing mice significantly reduced tumor growth and angiogenesis. CONCLUSIONS: These findings support the existence of a paracrine circuit wherein increased production of thrombopoietic cytokines in tumor and host tissue leads to paraneoplastic thrombocytosis, which fuels tumor growth. We speculate that countering paraneoplastic thrombocytosis either directly or indirectly by targeting these cytokines may have therapeutic potential. (Funded by the National Cancer Institute and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Platelets can extravasate into the primary ovarian tumor and induce proliferation and resistance to chemotherapy (Cho et al., 2012; Stone et al., 2012; Hu et al., 2017).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Stone et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citationPlatelet α-granules: Basic biology and clinical correlates
Blair, P., & Flaumenhaft, R. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.04.001 · Cited by 1,157
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R., Urbauer, D., Pennacchio, L. A., Cheng, J.-F., Nick, A. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803785 · Cited by 712
Self-citationInterleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Kaser, A., Brandacher, G., Steurer, W., Kaser, S., Offner, F. A., Zoller, H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., et al. (2001) · Blood · doi:10.1182/blood.v98.9.2720 · Cited by 667
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Chan, A. T. (2009) · JAMA · doi:10.1001/jama.2009.1112 · Cited by 557
Lineage-Specific Hematopoietic Growth Factors
Kaushansky, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052706 · Cited by 509
Stress hormone-mediated invasion of ovarian cancer cells
Sood, A. K., Bhatty, R., Kamat, A. A., Landen, C. N., Han, L., Thaker, P. H., Li, Y., Gershenson, D. M., Lutgendorf, S., & Cole, S. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1698 · Cited by 491
Self-citationRegulation of Tumor Angiogenesis by EZH2
Lu, C., Han, H. D., Mangala, L. S., Ali-Fehmi, R., Newton, C. S., Ozbun, L., Armaiz-Pena, G. N., Hu, W., Stone, R. L., Munkarah, A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.016 · Cited by 399
Self-citationInterleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Coward, J., Kulbe, H., Chakravarty, P., Leader, D., Vassileva, V., Leinster, D. A., Thompson, R., Schioppa, T., Nemeth, J., Vermeulen, J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0945 · Cited by 390
Self-citationGeneration of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Kim, M. P., Evans, D. B., Wang, H., Abbruzzese, J. L., Fleming, J. B., & Gallick, G. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.171 · Cited by 380
Beyond Clotting: The Powers of Platelets
Leslie, M. (2010) · Science · doi:10.1126/science.328.5978.562 · Cited by 332
Kaushansky, K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391107 · Cited by 325
Thrombocytosis Associated With Malignant Disease
LEVIN, J. (1964) · Archives of Internal Medicine · doi:10.1001/archinte.1964.03860100079008 · Cited by 295
Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor
McFarland-Mancini, M. M., Funk, H. M., Paluch, A. M., Zhou, M., Giridhar, P. V., Mercer, C. A., Kozma, S. C., & Drew, A. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901929 · Cited by 249
Self-citationThe role of platelet activation in tumor metastasis
Borsig, L. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.8.1247 · Cited by 199
Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer
Kamat, A. A., Merritt, W. M., Coffey, D., Lin, Y. G., Patel, P. R., Broaddus, R., Nugent, E., Han, L. Y., Landen, C. N., Spannuth, W. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1017 · Cited by 192
Self-citationLectures on Clinical Medicine, Delivered at the Hotel-Dieu, Paris
Trousseau, A., Bazire, P., & Cormack, J. R. (2010) · Medical Entomology and Zoology · Cited by 120
Platelets: Guardians of Tumor Vasculature
Ho‐Tin‐Noé, B., Goerge, T., & Wagner, D. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1370 · Cited by 111
Akl, E. A., van Doormaal, F. F., Barba, M., et al. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006652 · Cited by 95
Kluger, H. M., Lev, D. C., Kluger, Y., McCarthy, M. M., Kiriakova, G. M., Camp, R. L., Rimm, D. L., & Price, J. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0108 · Cited by 85
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer
Lü, C., Thaker, P. H., Lin, Y. G., Spannuth, W. A., Landen, C. N., Merritt, W. M., Jennings, N. B., Langley, R. R., Gershenson, D. M., Yancopoulos, G. D., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.12.028 · Cited by 62
Self-citationDeng, L., Broaddus, R. R., McCampbell, A. S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1189 · Cited by 60
Branehög, I., Ridell, B., Swolin, B., et al. (1975) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1975.tb01087.x · Cited by 59
Dual targeting of EphA2 and FAK in ovarian carcinoma
Shahzad, M., Lu, C.-H., Lee, J., Stone, R., Mitra, R., Mangala, L., Lu, Y.-L., Baggerly, K., Danes, C., Nick, A., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.11.8523 · Cited by 57
Self-citationThrombopoietin Production in Wild-Type and Interleukin-6 Knockout Mice with Acute Inflammation
Burmester, H., Wolber, E., Freitag, P., Fandrey, J., & Jelkmann, W. (2005) · Journal of Interferon and Cytokine Research · doi:10.1089/jir.2005.25.407 · Cited by 34
Research works printed but not linked: 2
- Riess L, 1872, Arch Anat Physiol Wissensch Med, 39, 237
- Akl EA, 2007, Cochrane Database Syst Rev, 3, CD006652
Cited by
Jayson, G. C., Kohn, E. C., Kitchener, H. C., & Ledermann, J. A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62146-7 · Cited by 1,850
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
Self-citationHarnessing cytokines and chemokines for cancer therapy
Propper, D. J., & Balkwill, F. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00588-9 · Cited by 989
Self-citationDiem, S., Schmid, S., Krapf, M., Flatz, L., Born, D., Jochum, W., Templeton, A. J., & Früh, M. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.07.024 · Cited by 986
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
Metadata
- Authors
- Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., Deavers, M. T., Vasquez, H. G., Urbauer, D., Landen, C. N., Hu, W., Gershenson, H., Matsuo, K., Shahzad, M. M. K., King, E. R., Tekedereli, I., Ozpolat, B., Ahn, E. H., Bond, V. K., Wang, R., Drew, A. F., Gushiken, F., Lamkin, D., Collins, K., DeGeest, K., Lutgendorf, S. K., Chiu, W., Lopez-Berestein, G., Afshar-Kharghan, V., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Queen Mary University of London (GB)
- University of Alabama at Birmingham (US)
- University of Maryland, Baltimore (US)
- University of Cincinnati (US)
- University of Iowa Holden Comprehensive Cancer Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-02-16
- Volume
- 366
- Issue
- 7
- Pages
- 610-618
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3296780
- OpenAlex
- W2117600467
- Cited by
- 812
- References
- 26
- Citations by year
- 2026: 39 · 2025: 45 · 2024: 71 · 2023: 53 · 2022: 81 · 2021: 58 · 2020: 64 · 2019: 50 · 2018: 55 · 2017: 81 · 2016: 58 · 2015: 58 · 2014: 47 · 2013: 28 · 2012: 23
- FWCI
- 33.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Funders
- U.S. Department of Defense (RC2GM092599, U54 CA151668, CA128797, BC085265, OC073399)
- Ovarian Cancer Research Fund
- RGK Foundation
- Queen Mary University of London
- Laura and John Arnold Foundation (BC085265, RC2GM092599, U54 CA151668, CA128797)
- Marcus Foundation
- National Institutes of Health (CA- 016672, BC085265, CA098258, CA083639)
- Medical Research Council
- National Cancer Institute (CA 109298, CA 016672, P50CA098258, U54CA151668, CA 101642, R01CA109298, T32CA009666, CA009666, CA140933, R01CA104825, R01CA140933, R01CA128797, P50CA083639, CA098258, P30CA016672, T32CA101642, CA 128797)
- National Institute of General Medical Sciences (RC2GM092599)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- epithelial ovarian cancer, thrombopoietin, interleukin-6, platelets, tumor growth, angiogenesis, paclitaxel, antiplatelet therapy, survival, paracrine signaling
- MeSH terms
- Interleukin-6 Inhibitors, Animals, Antibodies, Monoclonal, Blood Platelets, Disease Models, Animal, Female, Humans, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Paraneoplastic Syndromes, Platelet Count, Thrombocytosis, Thrombopoietin, Signal Transduction, Interleukin-6, Proportional Hazards Models, Mice, Knockout, Disease-Free Survival, Receptors, Interleukin-6, Mice, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.